Cobas Liat Analyzer
Payments companies reported to CMS as associated with Cobas Liat Analyzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cobas Liat Analyzer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cobas Liat Analyzer
These are the largest totals companies reported as associated with Cobas Liat Analyzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Icardi | Iowa City, IA | Anatomic Pathology & Clinical Pathology | $429.41 |
| Weihua Tang | Hiram, GA | Anatomic Pathology & Clinical Pathology | $127.16 |
| Sara Acree | Marietta, GA | Anatomic Pathology & Clinical Pathology | $127.15 |
| Jeannie Kenkare | Brookfield, CT | Family Medicine | $98.56 |
| Brian Cruz | Florence, SC | Emergency Medicine | $98.55 |
| Lamont Tyler | Henderson, NV | Family Medicine | $90.19 |
| Sonya Wilson | Austin, TX | Family Medicine | $90.19 |
| Christie Elliott | Reno, NV | Anatomic Pathology & Clinical Pathology | $87.37 |
| Kathryn Zimmerman | Greensboro, NC | Dentist | $40.94 |
| Charlotte Riddle | Hendersonville, NC | Pediatrics | $40.94 |
Prescribed Cobas Liat Analyzer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.